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OBJECTIVES: To investigate racial and ethnic differences
in graft and recipient survival in elderly kidney transplant
recipients.
DESIGN: Retrospective cohort.
SETTING: First-time, kidney-only transplant recipients
aged 60 and older of age at transplantation transplanted
between July 1996 and October 2010 (N = 44,013).
PARTICIPANTS: United Network for Organ Sharing
(UNOS) database.
MEASUREMENTS: Time to graft failure and death
obtained from the UNOS database and linkage to the
Social Security Death Index. Neighborhood poverty from
2000 U.S. Census geographic data.
RESULTS: Of the 44,013 recipients in the sample, 20%
were black, 63% non-Hispanic white, 11% Hispanic, 5%
Asian, and the rest “other racial groups.” In adjusted Cox
models, blacks were more likely than whites to experience
graft failure (hazard ratio (HR) = 1.23, 95% confidence
interval (CI) = 1.15–1.32), whereas Hispanics (HR = 0.77,
95% CI = 0.70–0.85) and Asians (HR = 0.70, 95%
CI = 0.61–0.81) were less likely to experience graft failure.
Blacks (HR = 0.84, 95% CI = 0.80–0.88), Hispanics
(HR = 0.68, 95% CI = 0.64–0.72), and Asians
(HR = 0.62, 95% CI = 0.57–0.68) were less likely than
whites to die after renal transplantation.
CONCLUSION: Elderly blacks are at greater risk of graft
failure than white transplant recipients but survive longer
after transplantation. Asians have the highest recipient and
graft survival, followed by Hispanics. Further studies are
needed to assess additional factors affecting graft and
recipient survival in elderly adults and to investigate out-
comes such as quality of life. J Am Geriatr Soc 63:2485–
2493, 2015.
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Over the past decade, the number of elderly adults livingwith end-stage renal disease (ESRD) has increased,
with approximately 48% of people with ESRD now aged
60 and older.1,2 Similarly, the percentage of kidney trans-
plant recipients aged 65 and older has increased from 2.4%
to 16% over the past 2 decades.3–6 Kidney transplantation
is the preferred treatment for most people with ESRD
because it offers longer survival and better quality of life
than dialysis for younger and older recipients.2,7,8
The rise in the number of older kidney transplant
recipients makes it increasingly important to understand
the factors affecting graft and recipient survival in the
elderly population. Race has been shown to be an impor-
tant factor affecting graft and recipient survival in kidney
transplant recipients.9–11 In the general population, black
kidney transplant recipients have been shown to have
worse graft and recipient survival than white recipients for
living and deceased donor transplants,10–14 but it is not
known whether the racial differences in graft and recipient
survival in the general kidney transplant population is also
seen in the elderly transplant recipient population. A con-
sensus workshop held on organ transplantation in elderly
adults emphasized the need to identify factors underlying
disparities in transplant outcomes in elderly adults.15
Understanding the role of race and other factors in graft
and recipient survival in elderly adults is crucial in reduc-
ing disparities and improving outcomes in this population.
The purpose of this study was to evaluate the associa-
tion between race/ ethnicity and graft and recipient sur-
vival after transplantation in elderly (age ≥60) kidney
transplant recipients. Another goal was to determine
potentially modifiable factors that may be associated with
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graft and recipient survival in elderly kidney transplant
recipients. It was hypothesized that, consistent with results
in the general kidney transplant recipient population,
elderly black adults would have worse graft and recipient
survival than white recipients and that Asians and Hispan-




Data were obtained from the United Network for Organ
Sharing (UNOS), the Social Security Death Index (SSDI),
and U.S. Census geographic data for 2000. UNOS is a pri-
vate organization that the government contracts to manage
the transplant waiting list, match donors to recipients, and
maintain information about every transplant recipient in
the United States, including follow-up data. The SSDI
database is a publicly available national database of death
records extracted from the U.S. Social Security Administra-
tion Death Master File. The Census 2000 data on neigh-
borhood poverty were linked to recipients’ residential ZIP
codes in the UNOS data using ZIP code tabulation areas.
Data from UNOS were merged with death date infor-
mation from the SSDI using unique encrypted recipient
codes to calculate posttransplantation survival time.
Study Population
The study population was drawn from the Organ Procure-
ment and Transplantation Network (OPTN) data received
from UNOS. The population was restricted to kidney
transplant recipients aged 60 and older who were trans-
planted between July 1996 and October 2010. Participants
were followed for outcomes through December 2011.
Forty-four thousand thirteen participants were included in
the analysis.
Measures
The main study outcomes were time from kidney trans-
plantation until death (recipient survival time) and time
from kidney transplantation until graft failure (graft sur-
vival time). Participants who did not experience either of
the two study outcomes were censored at the end of fol-
low-up (December 31, 2011). In the analysis of graft sur-
vival, recipients who died before graft failure were
censored at the time of death (death with a functioning
graft was censored rather than treated as graft failure) in
an attempt to capture only those with a recorded graft fail-
ure event, because death could be a result of various
causes, not just a failed graft.
The primary variable of interest was recipient race and
ethnicity (self-reported in most cases or as assessed by the
transplant center coordinator). Race and ethnicity was clas-
sified as black, white, Hispanic, Asian, and other. Recipient
demographic factors examined were age at transplant and
sex. Primary health insurance at transplantation and neigh-
borhood poverty were proxies for socioeconomic status
(SES). Insurance was categorized as private, public (Medi-
caid, Medicare fee for service, Medicare & Choice, Depart-
ment of Veterans Affairs, other government insurance, and
Medicare (further detail not collected)), or other (self, dona-
tion, free care, pending). The proportion of individuals
residing below the federal poverty level in each five-digit
ZIP code was used to estimate the neighborhood poverty
level using 2000 U.S Census Bureau data. High neighbor-
hood poverty was defined as areas in which more than 20%
of households were below the federal poverty level.16
Additional covariates of interest were recipient clinical
characteristics, including primary assigned cause of ESRD
categorized into five major groups (diabetes mellitus, hyper-
tension, cystic kidney disease, glomerulonephritis, other)
and years on dialysis (defined as number of years on dialysis
before transplantation). Donor characteristics assessed were
age and type of donor kidney (living or deceased) and, for
deceased donor, whether the graft came from a standard
criteria donor or extended criteria donor (ECD).
Transplant characteristics were also assessed as covari-
ates, as described below. To account for changes in kidney
transplantation practices over time, such as immunosup-
pression medications and allocation systems, a covariate
for year of kidney transplantation was created and then
categorized into three time periods (1996–2000, 2001–05,
2006–10). Other transplantation factors evaluated were
human leukocyte antigen (HLA) mismatch, cold ischemia
time, and reported incidence of any acute rejection. Partici-
pants were classified as having experienced acute rejection
episodes if they were reported in UNOS to have experi-
enced acute or hyperacute rejection before graft failure or
any episode of acute rejection recorded (whether or not
they were treated for it) or if they had a kidney biopsy that
confirmed acute rejection. Recipient age, donor age, and
cold ischemic time were analyzed as continuous variables.
Analysis
A retrospective cohort analysis of the UNOS database was
performed. Kaplan–Meier product-limit curves were gener-
ated and stratified according to race and ethnicity, and
log–rank statistics for differences between groups were cal-
culated. All predictor variables were evaluated for adher-
ence to the proportional hazards assumption using log–log
survival curves, an extended Cox approach using time
dependent variables, and a correlation analysis between
Schoenfeld residuals and ranked follow-up time.
To evaluate the effect of race and ethnicity on recipient
and graft survival, separate multivariable Cox proportional
hazard regression models were constructed for graft and
recipient survival time as a function of race and ethnicity.
Crude and adjusted hazard ratios (HRs) and 95% confi-
dence intervals (CIs) were computed for race and ethnicity
and for all other covariates. Effect estimates for continuous
variables, such as recipient age, donor age, years on dialy-
sis, and cold ischemia time, were calculated for a 10-unit
change. Variables were considered to be confounders if they
were associated with the exposure, race and ethnicity, and
the outcomes (graft failure and death). The fully conditional
specification method of multiple imputation was used for
other missing covariate information (n = 15,903 individu-
als).17 A complete case analysis was conducted as a sensitiv-
ity analysis. The final model was adjusted for recipient
age, sex, insurance, ESRD etiology, years on dialysis,
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neighborhood poverty level, donor type, donor age, period
of transplantation, cold ischemia time, HLA mismatch, and
any acute rejection. All analyses were conducted using SAS
version 9.4 (SAS Institute, Inc., Cary, NC), and data were
evaluated at the 0.05 significance level.
Approval for this study was obtained from the Emory
University institutional review board.
RESULTS
Table 1 shows the baseline demographic and clinical char-
acteristics of participants stratified according to race and
ethnicity. The median age of the 44,013 transplant recipi-
ents analyzed was 65 (interquartile range (IQR) 7.0). The
population was predominantly male (62.5%) and white
(62.4%). Diabetes mellitus was the most common cause of
ESRD (33.7%) in all races and ethnicities except blacks, in
whom it was hypertension (40.0%). Blacks had the highest
percentage of acute rejection episodes (11.8%), pretrans-
plant dialysis (93.9%), and receipt of kidneys from non-
ECDs (55.2%). Asians received the largest percentage of
kidneys from ECDs (31.5%). Hispanics had the largest
(41.1%) and whites the smallest (7.8%) percentage of peo-
ple living in the high-poverty areas.
Graft Survival
Race and Ethnicity
A total of 14.1% of recipients experienced a graft failure
event over the median of 4.3 years of follow up (IQR
5.2 years), and a greater proportion of blacks (19.2%)
than of whites (13.0%), Hispanics (11.6%), and other
races (16.6%) had graft failure. Table 2 shows the crude
and adjusted HRs for graft failure for all covariates exam-
ined. Blacks (HR = 1.23, 95% CI = 1.15–1.32) were more
likely, and Hispanics (HR = 0.77, 95% CI = 0.70–0.85)
and Asians (HR = 0.70, 95% CI = 0.61–0.81) were less
likely than whites to experience graft failure, after adjust-
ing for covariates (Table 2).
Recipient Demographic Characteristics
Recipients with public or other insurance were more likely
than those with private insurance to experience graft fail-
ure after adjusting for covariates (HR = 1.09, 95%
CI = 1.03–1.16). Recipients with high neighborhood pov-
erty were more likely than those with low neighborhood
poverty to experience graft failure (HR = 1.25, 95%
CI = 1.18–1.33) in the crude model, but this association
was not significant in the adjusted model (HR = 1.06,
95% CI = 0.99–1.14).
Recipient Clinical Characteristics
After adjusting for covariates, recipients with cystic kidney
disease (HR = 0.65, 95% CI = 0.59–0.73) and glomeru-
lonephritis (HR = 0.84, 95% CI = 0.77–0.91) were less
likely than those with diabetes mellitus to experience graft
failure. Hypertension was not associated with graft failure
(HR = 0.95, 95% CI = 0.89–1.02). A 10-year increase in
years on dialysis was associated with a 27% higher risk of
graft failure (HR = 1.27, 95% CI = 1.17–1.38) (Table 2).
Donor Characteristics
Participants who received a kidney from a non-ECD
(HR = 1.38, 95% CI = 1.26–1.51) and those who received
a kidney from an ECD (HR = 1.78, 95% CI = 1.61–1.97)
were more likely than those who received a kidney from a
living donor to experience graft failure (Table 2). A 10-
year increase in donor age was associated with a 16%
greater risk of graft failure (HR = 1.16, 95% CI = 1.13–
1.19) in the adjusted models.
Transplant Characteristics
Participants transplanted between 2001 and 2005 were less
likely than trose transplanted between 1996 and 2000 to
experience graft failure in the crude model (HR = 0.89,
95% CI = 0.84–0.95), but in the adjusted model, the dif-
ference was not statistically significant (HR = 0.94, 95%
CI = 0.88–1.01). Those transplanted between 2006 and
2010 were also less likely to experience graft failure than
those transplanted between 1996 and 2000 in crude
(HR = 0.74, 95% CI = 0.69–0.80) and adjusted
(HR = 0.74, 95% CI = 0.69–0.80) models.
Having two or more HLA mismatches was signifi-
cantly associated with greater likelihood of graft failure
than having no HLA mismatches.
Recipients who experienced any acute rejection epi-
sode were significantly more likely to have graft failure
than those without an acute rejection episode in crude
(HR = 2.53; 95% CI = 2.38–2.69) and adjusted
(HR = 2.25, 95% CI = 2.11–2.40) models.
Figure 1 shows Kaplan–Meier estimates for unad-
justed graft survival comparing elderly black, Hispanic,
and Asian with white renal transplant recipients from July
1996 to October 2010, with follow-up until December
2011 (median follow-up 4.3 years).
Participant Survival
Race and Ethnicity
A total of 37.4% of participants died over the median
4.6 years of follow-up (IQR 2.5–7.3 years), and a greater
proportion of whites (38.8%) than of blacks (37.7%), His-
panics (32.3%), and other races (27.6%) died. The median
survival time was 9.1 years for all participants, 8.8 years
for whites it was, 8.9 years for African Americans,
11.3 years for Asians, 10.3 years for Hispanics, and
8.7 years for persons of other races and ethnicities.
Table 2 shows crude and adjusted HRs for recipient death
according to race and other covariates examined. Blacks
(HR = 0.84, 95% CI = 0.80–0.88), Hispanics (HR = 0.68,
95% CI = 0.64–0.72), and Asians (HR = 0.62, 95%
CI = 0.57–0.68) all had a lower likelihood of death than
whites.
Recipient Demographics
Men had a 15% greater likelihood of death than women
(HR = 1.15, 95% CI = 1.11–1.19). Recipients with public
insurance had a 15% greater likelihood of death than
those with private insurance (HR = 1.15, 95%
CI = 1.11–1.19) in the adjusted model. A 10-year incre-
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ment in recipient age was associated with a 55%
(HR = 1.55, 95% CI = 1.50–1.60) and 47% (HR = 1.47,
95% CI = 1.42–1.52) higher rate of death in the crude
and adjusted models, respectively. Neighborhood poverty
was not associated recipient survival (HR1.01, 95%
CI = 0.97–1.06).
Recipient Clinical Characteristics
After adjusting for covariates, recipients with hypertension
as the primary etiology of ESRD (HR = 0.72, 95%
CI = 0.69–0.75), cystic kidney disease (HR = 0.43, 95%
CI = 0.40–0.46), and glomerulonephritis (HR = 0.54,
Table 1. Baseline Characteristics of Elderly (≥60) Renal Transplant Recipients from July 1996 to October 2010




White, n = 27,481
(62.4%)
Black, n = 8,903
(20.2%)
Hispanic,
n = 4,669 (10.6%)
Asian,
n = 2,095 (4.8%)
Other, n = 865
(2.0%)
Recipient demographic
Age, median (IQR) 65 (7.0) 65 (7.0) 64 (6.0) 64 (6.0) 65 (6.0) 64 (5.0)
Male, n (%) 27,512 (62.5) 17,669 (64.3) 5,128 (57.6) 2,957 (63.3) 1,238 (59.1) 520 (60.1)
Insurance type, n (%)
Private 13,585 (31.1) 9,407 (34.3) 2,183 (24.5) 1,097 (23.5) 1,664 (31.7) 234 (27.1)
Public or other 30,394 (68.9) 18,050 (65.8) 6,716 (75.5) 3,568 (76.5) 1,429 (68.3) 631 (72.9)
Neighborhood poverty, n (%)a
>20% 7,653 (17.4) 2,008 (7.6) 3,267 (37.8) 1,835 (41.1) 245 (12.1) 298 (35.6)
≤20% 34,858 (79.2) 24,536 (92.4) 5,370 (62.2) 2,632 (58.9) 1,782 (87.9) 538 (64.3)
Employed, n (%)a
No 19,393 (81.1) 11,341 (77.9) 4,212 (86.2) 2,417 (88.1) 1,053 (82.0) 370 (84.7)
Yes 4,513 (18.9) 3,211 (22.1) 676 (13.8) 328 (11.9) 231 (18.0) 67 (15.3)
Recipient clinical
ESRD etiology, n (%)a
Diabetes mellitus 13,488 (33.7) 6,759 (27.8) 3,233 (38.1) 2,225 (50.8) 782 (38.9) 489 (60.4)
Hypertension 10,039 (25.1) 5,082 (20.9) 3,389 (40.0) 935 (21.4) 503 (25.0) 130 (16.0)
Cystic kidney
disease
3,598 (9.0) 2,964 (12.2) 290 (3.4) 228 (5.2) 91 (4.5) 25 (3.1)
Glomerulonephritis 6,128 (15.3) 4,536 (18.6) 703 (8.3) 469 (10.7) 321 (16.0) 99 (12.2)
Other 6,774 (16.9) 5,011 (20.6) 862 (10.2) 519 (11.9) 315 (15.7) 67 (8.3)
Pretransplantation dialysis, n (%)a
No 6,122 (13.9) 5,045 (18.4) 545 (6.1) 294 (6.3) 178 (8.5) 60 (7.0)
Yes 37,848 (86.1) 22,408 (81.6) 8,355 (93.9) 4,366 (93.7) 1,916 (91.5) 803 (93)
Years on dialysis,
median (IQR)a
2.47 (2.81) 2.02 (2.29) 3.44 (3.27) 3.15 (3.30) 3.09 (3.11) 3.35 (3.09)
Donor
Type of donor, n (%)a
Living 13,212 (30.0) 9,761 (35.5) 1,588 (17.8) 1,234 (26.4) 422 (20.1) 207 (23.9)
Deceased non-ECD 21,387 (48.6) 12,646 (46.0) 4,914 (55.2) 2,375 (50.9) 1,014 (48.4) 438 (50.6)
Deceased ECD 9,412 (21.4) 5,073 (18.5) 2,400 (27) 1,060 (22.7) 659 (31.5) 220 (25.4)
Age, mean  standard
deviation
43.2  16.0 43.3  15.7 43.1  16.4 42.2  16.0 44.7  17.6 43.4  16.0
Transplantation characteristics
Period of transplantation, n (%)
1996–2000 8,389 (19.1) 5,546 (20.2) 1,614 (18.1) 775 (16.6) 282 (13.5) 172 (19.9)
2001–2005 15,210 (34.6) 9,606 (35) 2,960 (33.2) 1,626 (34.8) 688 (32.8) 330 (38.2)
2006–2010 20,414 (46.4) 12,329 (44.9) 4,329 (48.6) 2,268 (48.6) 1,125 (53.7) 363 (42)
Number of HLA mismatches, n (%)a
0 3,897 (8.9) 3,046 (11.1) 294 (3.3) 419 (9.0) 80 (3.8) 58 (6.7)
1 1,901 (4.3) 1,446 (5.3) 222 (2.5) 157 (3.4) 46 (2.2) 30 (3.5)
2 4,605 (10.5) 3,300 (12.1) 609 (6.9) 470 (10.1) 142 (6.8) 84 (9.7)
3 8,535 (19.5) 5,834 (21.3) 1,411 (15.9) 880 (18.9) 254 (12.2) 156 (18.1)
4 8,948 (20.4) 5,342 (19.5) 2,003 (22.6) 950 (20.4) 479 (23.0) 174 (20.1)
5 10,402 (23.7) 5,557 (20.3) 2,745 (30.9) 1,184 (25.5) 691 (33.2) 225 (26.0)
6 5,536 (12.6) 2,827 (10.3) 1,590 (17.9) 591 (12.7) 391 (18.8) 137 (15.9)
Cold ischemia time,
median (IQR)
15 (18.0) 14 (19.0) 16.3 (13.0) 15.5 (15.0) 15 (14.3) 14 (13.5)
Acute rejection, n (%)
No 39,577 (89.9) 24,698 (89.9) 7,852 (88.2) 4,289 (91.9) 1,956 (93.4) 782 (90.4)
Yes 4,436 (10.1) 2,783 (10.1) 1,051 (11.8) 380 (8.1) 139 (6.6) 83 (9.6)
aMissing data: insurance type, 0.1%; neighborhood poverty, 3.4%; employment, 46.0%; end-stage renal disease (ESRD) etiology, 9.1%; pretransplantaiton
dialysis, 0.01%; years on dialysis, 20.2%; donor type, 0.004%; human leukocyte antigen (HLA) mismatch, 0.4%; cold ischemia time, 7.9%.
IQR = interquartile range; ECD = extended criteria donor.
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95% CI = 0.51–0.57) had a lower likelihood of death than
those with diabetes mellitus. A 10-year increase in years
on dialysis was associated with a 39% greater likelihood
of death (HR = 1.39, 95% CI = 1.33–1.45). Having three
or more HLA mismatches was significantly associated with
greater likelihood of death than having no HLA mis-
matches.
Donor Characteristics
Persons who received kidneys from non-ECDs (HR = 1.33,
95% CI = 1.25–1.41) and, more so, those who received
kidneys from ECDs (HR = 1.42, 95% CI = 1.33–1.52)
had a greater risk of death than those who received living-
donor kidneys (Table 2). A 10-year increase in donor age
was associated with a 6% greater likelihood of death
(HR = 1.06, 95% CI = 1.05–1.08).
Transplant Characteristics
Recipients transplanted from 2001 to 2005 (HR = 0.86,
95% CI = 0.83–0.90) and 2006 to 2010 (HR = 0.66,
95% CI = 0.63–0.70) had a lower likelihood of death than
transplanted from 1996 to 2000. Recipients who experi-
enced an acute rejection episode had a greater likelihood
of death than those who did not in the crude (HR = 1.35,
95% CI = 1.29–1.41) and adjusted (HR = 1.26, 95%
CI = 1.20–1.32) model. Figure 2a–c shows Kaplan–Meir
Table 2. Unadjusted and Adjusted Hazard of Death and Graft Failure in Elderly (≥60) Renal Transplant Recipi-
ents from July 1996 to October 2010 According to Race and Ethnicity
Characteristic
Death Graft Failure
Crude Adjusteda Crude Adjusteda
Hazard Ratio (95% Confidence Interval)
Recipient demographic
Race and ethnicity (reference white)
African American 1.02 (0.98–1.07) 0.84 (0.80–0.88)b 1.60 (1.51–1.69)b 1.23 (1.15–1.32)b
Hispanic 0.81 (0.76–0.86)b 0.68 (0.64–0.72)b 0.89 (0.81–0.98)b 0.77 (0.70–0.85)b
Asian 0.71 (0.65–0.78)b 0.62 (0.57–0.68)b 0.85 (0.74–0.97)b 0.70 (0.61–0.81)b
Other 1.02 (0.92–1.14) 0.82 (0.74–0.92)b 1.27 (1.08–1.50)b 1.05 (0.88–1.25)
Agec 1.55 (1.50–1.60)b 1.47 (1.42–1.52) 1.02 (0.96–1.08) 0.94 (0.89–1.00)
Male 1.23 (1.19–1.27)b 1.15 (1.11–1.19)b 1.07 (1.02–1.13)b 1.04 (0.98–1.09)
Insurance type public and other (reference private) 1.39 (1.34–1.44)b 1.15 (1.11–1.19)b 1.26 (1.19–1.33)b 1.09 (1.03–1.16)b
Neighborhood poverty >20% (high poverty) 1.03 (0.99–1.07) 1.01 (0.97–1.06) 1.25 (1.18–1.33)b 1.06 (0.99–1.14)
Clinical
ESRD etiology (reference diabetes mellitus)
Hypertension 0.79 (0.76–0.82)b 0.72 (0.69–0.75)b 1.05 (0.98–1.12) 0.95 (0.89–1.02)
Cystic kidney disease 0.46 (0.43–0.50) 0.43 (0.40–0.46) 0.66 (0.59–0.73) 0.65 (0.59–0.73)
Glomerulonephritis 0.59 (0.56–0.62)b 0.54 (0.51–0.57)b 0.82 (0.75–0.89)b 0.84 (0.77–0.91)b
Other 0.76 (0.72–0.80)b 0.67 (0.64–0.70)b 0.95 (0.88–1.03) 0.93 (0.87–1.01)
Years on dialysisc 1.39 (1.33–1.46)b 1.39 (1.33–1.45)b 1.49(1.39–1.59)b 1.27 (1.17–1.38)b
Donor
Type (reference living)
Deceased non-ECD 1.43 (1.38–1.49)b 1.33 (1.25–1.41)b 1.54 (1.44–1.65)b 1.38 (1.26–1.51)b
Deceased ECD 1.88 (1.80–1.97)b 1.42 (1.33–1.52)b 3.06 (2.85–3.28)b 1.78 (1.61–1.97)b
Agec 1.09 (1.08–1.10)b 1.06 (1.05–1.08)b 1.25 (1.23–1.27)b 1.16 (1.13–1.19)b
Transplant
Period of transplant (reference 1996–2000)
2001–2005 0.88 (0.85–0.92)b 0.86 (0.83–0.90)b 0.89 (0.84–0.95)b 0.94 (0.88–1.01)
2006–2010 0.73 (0.69–0.76)b 0.66 (0.63–0.70)b 0.74 (0.69–0.80)b 0.74 (0.69–0.80)b
Number of HLA mismatches (reference 0)
1 1.05 (0.97–1.15) 1.10 (1.01–1.20) 0.99 (0.84–1.17) 1.04 (0.87–1.23)
2 0.93 (0.86–1.00)b 1.07 (0.99–1.15) 1.06 (0.93–1.20) 1.16 (1.01–1.33)
3 1.00 (0.94–1.07) 1.10 (1.03–1.17)b 1.22 (1.09–1.37) 1.25 (1.11–1.40)b
4 1.16 (1.09–1.23)b 1.12 (1.05–1.20)b 1.68 (1.50–1.88)b 1.35(1.20–1.51)b
5 1.19 (1.12–1.27)b 1.15 (1.08–1.22)b 1.76 (1.58–1.96)b 1.39 (1.24–1.56)b
6 1.22 (1.14–1.31)b 1.18 (1.10–1.26)b 1.99 (1.77–2.23)b 1.52 (1.34–1.71)b
Cold ischemia timed 1.14 (1.12–1.15)b 1.03 (1.01–1.05)b 1.21 (1.19–1.24)b 1.08 (1.05–1.11)b
Acute rejection 1.35 (1.29–1.41)b 1.26 (1.20–1.32)b 2.53 (2.38–2.69)b 2.25 (2.11–2.40)b
aAdjusted for race and ethnicity, any acute rejection, end-stage renal disease (ESRD) etiology, sex, human leukocyte antigen (HLA) mismatch, pretrans-
plantaiton dialysis, type of donor, recipient age, donor age, cold ischemia time, insurance, neighborhood poverty, and period of transplantation.
bP < .05.
cEffect estimate calculated for a 10-year change in age.
dEffect estimate calculated for a 10-year change in time on dialysis.
eEffect estimate calculated for a 10-hour change in time ischemia time.
ECD = extended criteria donor.
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estimates for unadjusted recipient survival in black, His-
panic, and Asian recipients compared with white recipients
over a median follow-up of 4.6 years.
Using complete-case analysis, multivariable results for
effect of race and ethnicity on recipient or graft survival
did not differ significantly from the main analysis; simi-
larly, stratifying according to age (60–70 vs >70) did not
yield significant differences in trends for recipient and graft
survival (S1 and S2).
DISCUSSION
This study sought to evaluate the effect of race and ethnic-
ity on graft and recipient survival in elderly (≥60) kidney
transplant recipients and to determine other factors that
may be associated with graft and recipient survival. A con-
sensus study on organ transplantation in elderly adults
found that there was a lack of data addressing age in
minority and nonminority transplant recipients and
stressed the need for studies identifying biological, behav-
ioral, and social mechanisms contributing to long-term
posttransplantation outcomes in elderly adults.15
The major findings of the current study were that
blacks were more likely than whites to experience graft
failure (HR = 1.23, 95% CI = 1.15–1.32), whereas His-
panics (HR = 0.77, 95% CI = 0.70–0.85) and Asians
(HR = 0.70, 95% CI = 0.61–0.81) were less likely to
experience graft failure. Second, blacks (HR = 0.84, 95%
CI = 0.80–0.88), Hispanics (HR = 0.68, 95% CI = 0.64–
0.72), and Asians (HR = 0.62, 95% CI = 0.57–0.68) were
less likely than whites to die after renal transplantation.
These results indicate that race and ethnicity may be an
independent risk factor for graft failure in elderly adults
but does not necessarily affect recipient survival in the
same manner. These findings support previous studies in
the general kidney transplant population showing superior
recipient and graft survival in Hispanics18–20 and Asians21
and worse graft survival in blacks than whites.9,11,22
Although recipient survival has been shown to be equiva-
lent11,23 or worse10,24,25 in blacks than nonblacks, the cur-
rent study found greater recipient survival in blacks aged
60 and older than in whites.
Previous studies have shown that the half-life of renal
allografts after transplantation appears to be 30% to 40%
A B
C
Figure 1. Kaplan–Meier estimates showing unadjusted graft survival in elderly renal transplant recipients from July 1996 to
October 2010, with recipient follow-up until December 2011.
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shorter in blacks than whites.10,26 In pediatric transplant
recipients, blacks had the lowest graft survival rates before
the 3-year mark, when Medicare eligibility ends.27 It could
be that biological factors affect graft loss more than
socioeconomic factors in elderly black adults because they
remain eligible for Medicare more than 3 years after trans-
plantation and are better able to afford immunosuppres-
sive medication than those who are younger than 65, who
lose Medicare eligibility after 3 years.
The current results on graft survival support the “His-
panic paradox,” which has shown that, although Hispan-
ics have low SES similar to that of blacks, their mortality
is equal to or lower than that of non-Hispanic whites in
the United States.18,28 This paradox is described in the
transplantation population and is hypothesized to be
related to age, occurring predominantly in middle-aged
and older Hispanics.18,29,30 Previous studies have showed
that socioeconomic characteristics of individual neighbor-
hoods may have a vital but underappreciated effect on
health outcomes, even more-so than individual SES (e.g.,
income and employment status).31–34 This study showed
that insurance but not neighborhood poverty was associ-
ated with graft and recipient survival, however, SES is
complex and multifactorial and may not be fully repre-
sented by a single variable.34,35 Therefore, an observed
racial or ethnic disparity may not be completely indepen-
dent of SES; 36 neither can socioeconomic differences com-
pletely account for these disparities.37–39 In addition to
psychosocial factors and access to care, other biological
factors such as genetic, immune, and pharmacokinetic fac-
tors may contribute to poorer graft outcomes in lacks.
The findings of the current study differ from those of
previous studies, which showed no difference in 5-year
recipient survival rates between black and white recipi-
ents.11 One study found no significant difference in 1- and
5-year recipient survival rates between black and nonblack
recipients of kidneys from living and deceased donors.23
The current study showed that elderly recipients receiving
kidneys from ECDs have the greater likelihood of
death.40,41 Increased immunosuppression use and a higher
rate of acute rejection, which also contributes to height-
ened immunosuppression and thus more deaths, may
explain this.40
Blacks, Hispanics, and Asians were less likely to die
after renal transplantation than whites, but blacks had
worse graft survival than whites. The reason for this para-
dox is unclear, but a possible explanation is that blacks
and Hispanics who are selected for transplantation may
have a lower cardiovascular disease burden and less-severe
comorbidities than whites, creating a survival bias, with
A B
C
Figure 2. Kaplan–Meier estimates showing unadjusted survival of elderly renal transplant recipients from July 1996 to October
2010, with recipient follow-up until December 2011.
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the healthiest candidates being presented for transplanta-
tion. It has also been suggested that older, sicker Hispanics
return to their country of origin, resulting in fewer
reported deaths.42,43 Alternatively, heightened immunolog-
ical response to the graft may cause a higher rate of graft
loss in blacks 44–47 but not necessarily lead to greater risk
of death. A survival paradox also exists in Hispanics and
older non-Hispanic blacks on dialysis. A previous study
found that Hispanic individuals undergoing dialysis had
lower mortality risk than non-Hispanic whites in all age
groups and that blacks aged 30 and older had a lower
mortality risk than whites.48 Another study found that
Hispanics on dialysis had lower mortality than whites in
all age groups, but in blacks, the lower mortality was evi-
dent only in those aged 40 and older.42
Hypertension was the leading cause of ESRD in black
recipients, supporting previous studies showing that blacks
are more likely to be labelled as having hypertensive renal
disease even when other causes of ESRD exist.49,50
Its retrospective nature and the inability to adjust for
unknown or unmeasured confounders limited the current
study. The acute rejection variable may not have captured
everyone with an acute rejection. Also, according to
UNOS, as of November 2011, the percentage of deaths
accessible in the Social Security Death Master File
decreased significantly because of data release problems
with the Social Security Administration. As such, persons
who died during the last month of follow-up in the current
study (November 2011 to December 2011) might not have
been accurately captured. In addition, because the outcome
of interest was graft failure, recipients who died with a
functioning graft were censored and not counted as failed
grafts, even though it is possible that incipient graft failure
was the reason for death. A unique strength of the study is
the fact that all persons in the UNOS database who
received a transplant during the specified period were
examined, and thus, the results are representative of the
elderly U.S. transplant population.
CONCLUSION
Elderly black, Hispanic, and Asian transplant recipients had
higher survival rates than whites, but only blacks had worse
graft survival than whites. Further studies may be needed to
identify specific immunological and nonimmunological fac-
tors such as currently unmeasured socioeconomic effects
that may affect graft loss. Identifying potentially novel fac-
tors that may explain these differences is essential to
improve graft survival in elderly adults and ensure equity in
outcomes across all racial and ethnic groups.
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